India, March 19 -- The shares of the generic and specialty pharmaceutical companies are in the spotlight after the company setting up of a greenfield formulations manufacturing facility with an approved investment of upto Rs 533 crores.

With a market capitalization of Rs 62,759.67 crore, the shares of Alkem Laboratories Ltd were trading at Rs 5,249.00 per share, decreasing around 1.86 percent as compared to the previous closing price of Rs 5,348.60 apiece.

Expansion According to the company filing, Alkem Laboratories' plan to set up a greenfield formulations facility in Ujjain reflects its strategic focus on expanding manufacturing capacity and strengthening its domestic footprint. The phased investment of up to Rs533 crore indicates a ...